Abstract
Formalin-fixed, paraffin-embedded (FFPE) bone marrow trephines are widely used in pathology, because they best preserve the morphological details of the bone marrow. However, DNA isolated from FFPE material is fragmented, limiting the size of amplification products, which is a challenge for all sequencing applications.
Pyrosequencing® is a quantitative and sensitive method for the detection of single-nucleotide variations (SNVs) in DNA samples. Pyrosequencing can easily be performed in a 96-well-plate format with a cost-effective medium-sized throughput.
This chapter provides a general outline of SNV detection in FFPE bone marrow trephines, including a detailed protocol of the Pyrosequencing procedure and guidelines for the design of new assays and evaluation of Pyrograms. The strengths of this approach are discussed using myeloproliferative neoplasms as an example.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tefferi A, Vardiman J (2008) Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 22:14–22
Cleary C, Kralovics R (2013) Molecular basis and clonal evolution of myeloproliferative neoplasms. Clin Chem Lab Med 51:1889–1896
Tefferi A (2010) Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 24:1128–1138
Zhang S-J, Rampal R, Manshouri T et al (2012) Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome. Blood 119:4480–4485
Tefferi A (2013) Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management. Am J Hematol 88:141–150
Buhr T, Hebeda K, Kaloutsi V et al (2012) European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 97:360–365
Hasemeier B, Geffers R, Bartels S et al (2013) Archival bone marrow trephines are suitable for high-throughput mutation analysis using next generation sequencing technology. Haematologica 98:e115–e116
Dietrich D, Uhl B, Sailer V et al (2013) Improved PCR performance using template DNA from formalin-fixed and paraffin-embedded tissues by overcoming PCR inhibition. PLoS One 8:e77771
Harrington CT, Lin EI, Olson MT et al (2013) Fundamentals of pyrosequencing. Arch Pathol Lab Med 137:1296–1303
James C, Ugo V, Le Couédic JP et al (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434:1144–1148
Soriano G, Heaney M (2013) Polycythemia vera and essential thrombocythemia: new developments in biology with therapeutic implications. Curr Opin Hematol 20:169–175
Yoshida K, Sanada M, Shiraishi Y et al (2011) Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478:64–69
Murati A, Brecqueville M, Devillier R et al (2012) Myeloid malignancies: mutations, models and management. BMC Cancer 12:304
Lasho TL, Jimma T, Finke CM et al (2012) SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival. Blood 120:4168–4171
Brecqueville M, Rey J, Bertucci F et al (2012) Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms. Genes Chromosomes Cancer 51:743–755
Shih AH, Chung SS, Dolezal EK et al (2013) Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia. Haematologica 98:908–912
Lehmann U, Bartels S, Hasemeier B et al (2013) SRSF2 mutation is present in the hypercellular and prefibrotic stage of primary myelofibrosis. Blood 121:4011–4012
Reineke T, Jenni B, Abdou MT et al (2006) Ultrasonic decalcification offers new perspectives for rapid FISH, DNA, and RT-PCR analysis in bone marrow trephines. Am J Surg Pathol 30:892–896
Issa JP, Gharibyan V, Cortes J et al (2005) Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate. J Clin Oncol 23:3948–3956
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Bartels, S., Lehmann, U. (2015). Analysis of Mutational Hotspots in Routinely Processed Bone Marrow Trephines by Pyrosequencing® . In: Lehmann, U., Tost, J. (eds) Pyrosequencing. Methods in Molecular Biology, vol 1315. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2715-9_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2715-9_8
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2714-2
Online ISBN: 978-1-4939-2715-9
eBook Packages: Springer Protocols